Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Esnouf, C. Prowse (1977)
The gamma-carboxy glutamic acid content of human and bovine prothrombin following warfarin treatment.Biochimica et biophysica acta, 490 2
J. Greaves, P. Ayres (1967)
Heritable Resistance to Warfarin in RatsNature, 215
C. Boyle (1960)
Case of Apparent Resistance of Rattus norvegicus Berkenhout to Anticoagulant PoisonsNature, 188
J. Gill, A. MacNicoll (1991)
Determination of the susceptibility of wild populations of the Norway rat (Rattus norvegicus) to the anticoagulant rodenticide brodifacoum, 78
(1995)
Feare CJ (eds) Advances in vertebrate pest
M. Hadler, A. Buckle (1992)
FORTY FIVE YEARS OF ANTICOAGULANT RODENTICIDES — PAST, PRESENT AND FUTURE TRENDS, 15
R. Mcdonald, S. Harris, G. Turnbull, Peter Brown, M. Fletcher (1998)
Anticoagulant rodenticides in stoats (Mustela erminea) and weasels (Mustela nivalis) in EnglandEnvironmental Pollution, 103
R. Redfern, J. Gill (1978)
The development and use of a test to identify resistance to the anticoagulant difenacoum in the Norway rat (Rattus norvegicus)Journal of Hygiene, 81
(2001)
Distribu - tion of resistance to second generation anticoagulant rodenticides in the Norway rat ( Rattus norvegicus Berk . ) in England 1995 ^ 98
A. Howe, William Webster (2000)
Warfarin exposure and calcification of the arterial system in the ratInternational Journal of Experimental Pathology, 81
J. Fraser, Y. Otawara, P. Price (1988)
1,25-Dihydroxyvitamin D3 stimulates the synthesis of matrix gamma-carboxyglutamic acid protein by osteosarcoma cells. Mutually exclusive expression of vitamin K-dependent bone proteins by clonal osteoblastic cell lines.The Journal of biological chemistry, 263 2
A. Zimmermann, J. Matschiner (1974)
Biochemical basis of hereditary resistance to warfarin in the rat.Biochemical pharmacology, 23 6
T. Harauchi, K. Takano, M. Matsuura, T. Yoshizaki (1986)
Liver and plasma levels of descarboxyprothrombin (PIVKA II) in vitamin K deficiency in rats.Japanese journal of pharmacology, 40 4
A. MacNicoll, J. Gill (1993)
Revised methodology for a blood-clotting response test for identification of warfarin-resistant Norway rats (Rattus norvegicus)Eppo Bulletin, 23
R. Redfern, J. Gill, M. Hadler (1976)
Laboratory evaluation of WBA 8119 as a rodenticide for use against warfarin-resistant and non-resistant rats and miceJournal of Hygiene, 77
R. Pospischil, H. Schnorbach (1994)
RACUMIN PLUS , A NEW PROMISING RODENTICIDE AGAINST RATS AND MICE, 16
M. Hadler, R. Redfern, F. Rowe (1975)
Laboratory evaluation of difenacoum as a rodenticideJournal of Hygiene, 74
G. Kerins, A. MacNicoll (1999)
Comparison of the half-lives and regeneration rates of blood clotting factors II, VII, and X in anticoagulant-resistant and susceptible Norway rats (Rattus norvegicus Berk.).Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology, 122 3
G. Luo, P. Ducy, M. McKee, G. Pinero, E. Loyer, R. Behringer, G. Karsenty (1997)
Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA proteinNature, 386
(2001)
Distribution of resistance to second generation anticoagulant rodenticides in the Norway rat (Rattus norvegicus
R. Redfern, J. Gill (1980)
Laboratory evaluation of bromadiolone as a rodenticide for use against warfarin-resistant and non-resistant rats and miceJournal of Hygiene, 84
Ian Newton, I. Wyllie, P. Freestone (1990)
Rodenticides in British barn owls.Environmental pollution, 68 1-2
(1988)
Genetics of difenacoum resistance in the rat
Resistance to 4-hydroxycoumarin anticoagulant rodenticides has been a problem in some local foci for a number of years. One method of managing resistance could be to use synergists in conjunction with anticoagulants. We investigated the effect of administering cholecalciferol and coumatetralyl alone and in a synergistic mixture to anticoagulant-resistant rats by monitoring plasma factor X concentrations. The study showed that the efficacy of the compounds was significantly improved when they were used together. This synergistic effect led to an increased mortality in female rats that had been treated with both compounds compared to both a control group and groups of rats that had received the compounds singly. An unexpected result from this work was that cholecalciferol when given on its own to rats caused a decrease in plasma factor X concentration. We hypothesise that this effect was due to a vitamin D-induced increase in production of vitamin K-dependent proteins leading to a saturation of the carboxylation process and hence to a significant number of factor X molecules being under-carboxylated and therefore dysfunctional. It is suggested that the reduction in factor X levels is a major component of the increased efficacy of the anticoagulant/calciferol mixture and also that effects on other vitamin K-dependent proteins, e.g. matrix GLA protein, may play a role in the increased mortality seen in female rats.
Comparative Clinical Pathology – Springer Journals
Published: Jan 1, 2002
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.